Tuberculosis DNA vaccine - Sequella
Alternative Names: Heat shock protein 65 DNA vaccine; hsp65 DNA vaccineLatest Information Update: 12 Oct 2010
At a glance
- Originator National Institute for Medical Research
- Developer National Institute for Medical Research; Sequella
- Class DNA vaccines; Gene therapies; Tuberculosis vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Tuberculosis
Most Recent Events
- 22 Feb 2010 Discontinued - Preclinical for Tuberculosis in United Kingdom (unspecified route)
- 22 Feb 2010 Discontinued - Preclinical for Tuberculosis in USA (unspecified route)
- 21 Aug 2007 Preclinical development is ongoing in the US